Q1 2026 Advanced Enzyme Technologies Ltd Earnings Call Transcript
Key Points
- Advanced Enzyme Technologies Ltd (BOM:540025) reported a 20% year-on-year growth in revenue, reaching INR 1,859 million.
- The company achieved its highest ever quarterly revenue, driven by strong performance in the human healthcare and animal healthcare segments.
- EBITDA increased by 10% year-on-year and 24% quarter-on-quarter, with a margin of 30%.
- Profit after tax grew by 16% year-on-year and 51% quarter-on-quarter, with a margin of 22%.
- The company is expanding its clean energy initiatives, collaborating with JC Biotech and Solar Power Systems to meet electricity needs sustainably.
- The bioprocessing segment experienced a 6% year-on-year decline and a 15% sequential drop in revenue.
- Gross margins have decreased to around 72-73% from historical levels above 75%, partly due to changes in product mix and tariffs.
- The company is absorbing a 10% tariff on exports to the USA, impacting profitability.
- Employee costs have increased, attributed to salary adjustments and new hires.
- The company faces uncertainty in the global market, particularly with tariffs and regulatory changes affecting future performance.
Ladies and gentlemen, good day and welcome to the Advanced Enzyme technologies Limited Q1 S526 earnings conference call.
As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing, then 0 on a touchtone phone. Please note that this call is being recorded.
With this, I now hand the conference over to Mr. Ronak Sara, investor relations manager for opening comments.
Thank you and over to you, sir.
Thank you. Good evening, everyone.
Welcome to the Advanced in design technologies Q1 and FI 26 earnings conference call.
We hope you have gone through our financials press release and the PPT which has been posted in the installation section of our website.
We have with us Mr. V. L. Rathi, chairperson Mr. Mukund M. Kabra, full-time
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
